According to the Zhitong Finance App, Tiger Pharmaceuticals (03347) issued an announcement. As of October 30, 2026, the company had repurchased 20.963,500 shares of the company's shares through a special stock repurchase account through centralized bidding transactions, accounting for 2.4347% of the company's current total share capital and 2.8410% of the company's current total A-share capital. The highest transaction price was 42.78 yuan/share, the lowest transaction price was 38.22 yuan/share, and the total transaction amount was 824 million yuan (excluding transaction fees). This repurchase complies with the requirements of the company's share repurchase plan and related laws and regulations.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.